Apr 23, 2025 3:51 PM
BACK TO TOP
KSE100
117,226.14
-1204.21
(-1.02%)
ALLSHR
73,365.85
-506.80
(-0.69%)
KSE30
36,019.66
-383.53
(-1.05%)
KMI30
176,989.57
-1908.99
(-1.07%)
BKTI
28,249.92
-336.25
(-1.18%)
OGTI
27,716.70
-163.48
(-0.59%)
KMIALLSHR
51,147.71
-322.15
(-0.63%)
PSXDIV20
44,760.24
-362.71
(-0.80%)
UPP9
37,279.39
-381.73
(-1.01%)
NITPGI
29,136.79
-257.33
(-0.88%)
NBPPGI
31,654.91
-289.07
(-0.90%)
MZNPI
21,792.29
-260.15
(-1.18%)
JSMFI
32,959.86
-468.85
(-1.40%)
ACI
19,290.73
-300.78
(-1.54%)
JSGBKTI
32,212.63
-446.35
(-1.37%)
MII30
16,319.73
-174.01
(-1.06%)
HBLTTI
16,517.43
22-04-2025
5.06
(0.03%)
Liven Pharma Limited
PHARMACEUTICALS
Rs.77.03
-1.02
(-1.31%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Apr 23, 2025 3:36 PM
REG
FUT
ODL
Open
78.00
High
79.00
Low
75.01
Volume
4,439
CIRCUIT BREAKER
70.25 — 85.86
DAY RANGE
75.01 — 79.00
52-WEEK RANGE
9.11 — 242.45
Ask Price
77.03
Ask Volume
0
Bid Price
77.03
Bid Volume
0
LDCP
78.05
VAR
41.50
HAIRCUT
60.00
P/E Ratio (TTM) **
6.61
1-Year Change *
673.39%
YTD Change *
-48.83%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Liven Pharma Limited was incorporated in Pakistan as a private Limited Company on October 21, 1991 and was converted into a public limited company on April 30, 1992 under the Companies Ordinance, 1984 (Repealed with the enactment of the Companies Act, 2017). The principal activity of the Company is the manufacturing of pharmaceuticals and allied products.

KEY PEOPLE
Kashif Hussain SiddiquieCEO
Atif Hussain SiddiqiChairman
Muhammad SaeedCompany Secretary
ADDRESS

49-Km, Multan Road, Lahore

WEBSITE

www.liven-pharma.com

REGISTRAR

F.D. Registrar Services SMC (Pvt.) Ltd., 1705,17th Floor, Saima Trade Tower A, I.I. Chundrigar Road, Karachi

AUDITOR

M/s Reanda Haroon Zakaria Aamir Salman Rizwan & Company, Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
7,166,899.47
Shares
93,040,367
Free Float
9,304,037
Free Float
10.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Mar 17, 2025Financial result for Quarter / Half Yearly 2024-12-31 View   PDF
Mar 17, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Financial Results for the Half Year Ended 31-12-2024 PDF
DateTitleDocument
Apr 21, 2025Board Meeting View   PDF
Mar 10, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Board Meeting PDF
DateTitleDocument
Feb 20, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Change of Statutory Auditors PDF
Feb 18, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders PDF
Jan 23, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Disclosure of Interest by a Director CEO or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.4. of PSX Regulations PDF
Jan 8, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Progress Report PDF
Jan 6, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) UNUSUAL MOVEMENT IN THE PRICE OF SHARES PDF
Jan 6, 2025LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Change of Manangement PDF
Jan 3, 2025LIVEN | Liven Pharma Limited - Material Information - Change of Management PDF
Dec 19, 2024LIVEN | Liven Pharma Limited (Formerly: Landmark Spinning Industries Limited) Auditors Certificate PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales
Profit after Taxation(11,178)(12,325)(14,289)(14,634)
EPS(0.92)(1.02)(1.18)(1.21)
Q2 2025Q1 2025Q3 2024Q2 2024
Sales17,12688,910
Profit after Taxation(9,491)147,588(2,532)(2,646)
EPS(0.10)12.17(0.21)(0.22)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
EPS Growth (%)9.8013.562.4813.57
PEG(1.01)(1.06)(4.29)(1.52)

Payouts

Financial Reports